Hyperfine, a leading health technology company renowned for its groundbreaking Swoop® system, the first FDA-cleared portable magnetic resonance (MR) brain imaging system, has announced an upcoming analyst and investor education webcast scheduled for Tuesday, June 25, 2024, at 2:00 PM Eastern Time. The session will focus on clinical advancements in ultra-low-field (ULF) MR imaging.

Hyperfine, Inc., will moderate the event. Key opinion leaders will discuss the utilization of the Swoop® system in critical care, stroke management, and dementia, including Alzheimer’s treatment workflows. The webcast will conclude with an interactive Q&A session.

Neuroradiologist and MR Medical Director at Jefferson Abington Hospital, will share insights into their adoption of the Swoop® system.

Chief of the Division of Neurocritical Care at Mass General Hospital and Associate Professor of Neurology at Harvard Medical School, will discuss the application of the Swoop® system in acute ischemic stroke triage.

Neuro Magnetic Resonance Imaging at Barnes Jewish Hospital, Mallinckrodt Institute of Radiology, and Associate Professor of Radiology and Neurology at Washington University in St. Louis, will address imaging requirements in dementia and Alzheimer’s care.

The live audio webcast, along with an archived presentation, will be accessible via the Investors page of Hyperfine, Inc.'s corporate website at https://investors.hyperfine.io. Participants are encouraged to register at least fifteen minutes before the commencement of the call.

The Swoop® Portable MR Imaging® system holds FDA clearance for brain imaging across all age groups.

It represents a portable, ultra-low-field magnetic resonance imaging tool designed to generate images depicting the internal structure of the head, particularly in scenarios where a full diagnostic examination is impractical clinically. Interpreted by trained physicians, these images offer valuable diagnostic insights.

Additionally, the Swoop® system boasts CE certification in the European Union and UKCA certification in the United Kingdom. It is commercially available in select international markets.







Source: businesswire.com

Report Abuse